Aaron Sverdlov
John Hunter Hospital & University of Newcastle, NSW, Australia
Presentations this author is a contributor to:
Retrospective analysis of risk factors associated with cardiac hospital admissions in cancer patients treated with immune checkpoint inhibitors (#281)
12:45 PM
Joshua Bennetts
Lunch & Poster Viewing (Odd Numbers)
The clinically active PARP inhibitor Olaparib ameliorates Doxorubicin-induced Cardiotoxicity in both in vitro and In vivo model (#282)
1:00 PM
Dongqing Kelly Chen
Lunch & Poster Viewing (Even Numbers)
Chemotherapies and effects on cardiomyocyte viability: which drugs are directly cardiotoxic? (#302)
1:00 PM
Lohis Balachandran
Lunch & Poster Viewing (Even Numbers)
Carfilzomib-induced cardiotoxicity: mechanisms & potential treatments. (#286)
1:00 PM
Tatt Jhong Haw
Lunch & Poster Viewing (Even Numbers)
Overexpression of mitochondrial catalase in adipose tissue improves survival and cardiac cachexia in AOM-DSS model of colitis-associated colorectal cancer. (#283)
12:45 PM
Amanda Croft
Lunch & Poster Viewing (Odd Numbers)